NCT06907303
RNA Assays for Endometriosis Detection and Diagnosis
Enrolling by Invitation
Not specifiedAges 20–35ObservationalWren Laboratories LLC
~400 participants
Updated 2025-04-02 on ClinicalTrials.gov
What's tested:EndoDx
At a glance
Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Develop a gene signature that detects endometriosis
Measured over 12-18 months
Conditions
Where it's being run
2 sites across 2 statesConnecticut1
South Africa1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
a history of infertility more than 1 year
age 20-35 years
normal liver and kidney function, without gynaecological and other systemic disease
Exclusion
polycystic ovary syndrome, hyperprolactinemia
severe cardiovascular system, liver, kidney, and hematopoietic system disease
autoimmune disease
uterine fibroids, endometritis, non-vegetative ovarian cysts, ovarian malignancies, and internal genital tuberculosis
What this trial measures
- Develop a gene signature that detects endometriosis12-18 months
Gene expression levels in samples from endometriosis subjects and controls